Peter Rule is a senior executive with over three decades of experience driving fully integrated companies, ranging from ten to over 500 employees. Previous CEO positions include OptiScan BIomedical (ten years), Ekos Corporation (5 years, purchased by Boston Scientific), and PercuSurge (5 years, purchased by Medtronic). Peter was the founding Chairman of the Board of TheraSense (4 years, purchased by Abbott Laboratories), and the President and Chief Operating Officer of MiniMed (10 years, purchased by Medtronic).

Peter has built and rebuilt management teams in these various companies. He holds 48 issued US patents and has been an expert witness in patent disputes.

Peter holds a BS degree in economics from the University of Southern California (Magna Cum Laude) and a Masters in Business Administration from Harvard University.

Gil Rivas has 30 years of experience in the medtech industry, having led marketing, commercial, and business units for businesses up to $500m in revenue in the areas of heart failure, diabetes, cardiothoracic surgery, and interventional cardiology.

He has prior experience at various divisions of Johnson and Johnson, Baxter Healthcare, and Dexcom. He has also led marketing and commercial efforts at several successful medtech startups.

He has an undergraduate degree from The Wharton School and an MBA from the Kellogg School of Management.

Tan Rao is an experienced entrepreneur and product development leader with an established track record of driving new product introduction (NPI) initiatives in the semiconductor, consumer electronics and biomedical spaces. Passionate about identifying and bringing to market technology and/or business model innovations capable of substantively improving health and well-being outcomes for individuals of all ages. Areas of technical expertise include IoT, machine learning/AI, wireless connectivity, audio/video, industrial automation and digital transformation, embedded systems, and consumer products.

Norm Major is a senior technology executive with over three decades of experience driving R&D, engineering leadership, and commercialization across startups and global enterprises. As CEO of Majorspeed Canada Inc., he advises technology companies on scaling product innovation, technical strategy, and executive operations.

A former Director of Engineering at Cisco Systems, Norm led the development of several flagship networking platforms. He has since served as CTO, investor, and advisor to ventures in IoT, wireless power, digital payments, and graphene innovation. His portfolio includes successful exits at Nexage and MuAnalysis.

With deep expertise in engineering management, product development, and venture growth, Norm brings a pragmatic and results-driven approach to building market-ready technology. He holds a B.Eng. from McMaster University and pursued graduate studies at Stanford University.

Earl Cohen has over 40 years of experience in high tech on projects ranging from supercomputers to networking equipment to solid state disks, serving in roles including individual contributor, manager, CTO, and VP, and in environments ranging from start-ups to large corporations such as Cisco Systems.

Earl is an inventor on about 150 U.S. issued patents from the various projects he's worked on. He became a registered patent agent in 2005 and drafts patents and handles portfolio management and IP direction and priorities.

Earl also serves on LDT's Board of Directors as Life Science Angels designated board member.

Earl received an S.B. degree from M.I.T. (1978), and an M.S. (1980) and a PhD (1983) from U.C. Berkeley, all in Electrical Engineering and Computer Science.